semaglutide with hashimoto's and Hypothyroidism: Safety Guide Can a patient with Hashimoto's

The injection is given intramuscularly (IM) or subcutaneously (SC), depending on the healthcare provider's recommendation

Discard any remaining solution after this period regardless of visual appearance

Chen says its important to have a conversation with your doctor about what this means for your health and your expectations for taking the medication in the future

It may signal the need for a dose adjustment, a dietary change, or an investigation into whether your medication has been stored properly, which brings us right back to color and appearance

Patients who have a family history of medullary thyroid carcinoma, a very rare form of thyroid cancer, should also not take GLP-1 medications

Post-Semaglutide body: Wait to restart the GLP-1 agonist until bowel function and diet are tolerated